|Articles|July 22, 2009

Info for Authors

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content

Obesity Trials: Scaling Operations for High-Demand Therapeutics

ByHeidi Chen,Andy Studna, Senior Editor

December 5th 2025

© JHVEPhoto - © JHVEPhoto - stock.adobe.com

Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework

ByAndy Studna, Senior Editor

December 4th 2025

ACT Brief: Targeted Trial Growth, Site Startup Strains, and Leadership Shake-Up at FDA

ByAndy Studna, Senior Editor

December 4th 2025

CNS and Autoimmune Trials: Growth and Operational Implications

ByHeidi Chen,Andy Studna, Senior Editor

December 4th 2025

© Andrii Yalanskyi - © Andrii Yalanskyi - stock.adobe.com

New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup

ByAndy Studna, Senior Editor

December 3rd 2025

Info for Authors

Newsletter

Related Content

Obesity Trials: Scaling Operations for High-Demand Therapeutics

Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework

ACT Brief: Targeted Trial Growth, Site Startup Strains, and Leadership Shake-Up at FDA

CNS and Autoimmune Trials: Growth and Operational Implications

New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup

Trending on Applied Clinical Trials Online

ACT Brief: Targeted Trial Growth, Site Startup Strains, and Leadership Shake-Up at FDA

How the FDA’s CNPV Program Is Reshaping Trial Operations and Accelerated Review Strategies

Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework

Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial

New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup